Taizhou’s COVID-19 prevention and control experience with telemedicine features

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly around the world. As of May 30, 2020, a total of 84 568 confirmed COVID-19 cases have been recorded in China, with a mortality rate of approximately 5.5%. Taizhou is a prefecture-level city in Zhejiang Province. A total of 146 cases were diagnosed in this epidemic, with a fatality rate of 0%. This condition is due to the establishment of an “Internet+” diagnosis and treatment model based on online medical application (APP), telemedicine, WeChat service, and consultation hotline in Taizhou. Taizhou led in opening the “COVID-19 Prevention and Treatment Special Line” in China, which is conducive to pre-hospital screening, suppressing social panic, and clinical support. Hospitals also carried out related online lectures and popularization of science. We summarize Taizhou’s COVID-19 prevention and control experience with telemedicine features, with a view to providing reference for the control of the epidemic at home and abroad.

Keywords

COVID-19 / telemedicine / prevention experience

References

[1] Gong K, Xu Z, Cai Z, Chen Y, Wang Z. Internet hospitals help prevent and control the epidemic of COVID-19 in China: multicenter user profiling study. J Med Internet Res 2020; 22(4): e18908

[2] Little P, Stuart B, Andreou P, McDermott L, Joseph J, Mullee M, Moore M, Broomfield S, Thomas T, Yardley L. Primary care randomised controlled trial of a tailored interactive website for the self-management of respiratory infections (Internet Doctor). BMJ Open 2016; 6(4): e009769

[3] Ling L. Seven specific suggestions to the Wuhan Municipal Party Committee and Municipal Government. January 24, 2020. https://user.guancha.cn/main/content?id=231202&s=zwyess (in Chinese) (accessed March 8, 2020)

[4] Geldsetzer P. Use of rapid online surveys to assess people’s perceptions during infectious disease outbreaks: a cross-sectional survey on COVID-19. J Med Internet Res 2020; 22(4): e18790

Compliance with ethics guidelines

Cenyi Shao, Shijian Li, Feng Zhu, Dahai Zhao, Hui Shao, Haixiao Chen, and Zhiruo Zhang declare no conflicts of interest. This manuscript does not contain any studies with human or animal subjects and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.

RIGHTS & PERMISSIONS

2020 Higher Education Press